At Dermagnostix, we envision the next level for molecular diagnostics in human skin to improve patients’ lives and clinical practice in dermatology.
Why Dermatology?
Dermatologic diseases are the 4th most common cause of all human illnesses.
Every individual experiences a skin disease at least once during their lifetime.
7 of the 15 best selling drugs are used in dermatology already today and many more promising treatments are in the pipeline.
Conventional Diagnostics
... based on clinical view and histopathology are imprecise and impede the optimal use of the already available highly specific modern therapies in dermatology.
The Solution
... is to offer modern diagnostics for modern therapies. With our first test – PsorEx – to differentiate between eczema and psoriasis on molecular level we achieved a milestone for molecular diagnostics in dermatology.
Dermagnostix offers a comprehensive technological platform for fast and objective molecular diagnostics in dermatology to reduce health care costs and improve patient treatment.
Dermagnostix provides molecular diagnostic solution for dermatology - economic, fast, easy and precise.
www.dermagnostix.com
Location: Chile, De Valparaiso, Villa Alemana
Employees: 11-50
Founded date: 2020
Investors 1
Date | Name | Website |
08.07.2022 | Creative D... | creativede... |
Mentions in press and media 4
Date | Title | Description | Source |
08.12.2022 | European Innovation Council funds Dermagnostix with 2.5 mill... | The joint spin-off of Hahn-Schickard, Helmholtz Munich and TU Munich, Dermagnostix GmbH, was one of ... | bio-m.org/... |
19.08.2022 | Dermagnostix: new capital for better diagnosis of psoriasis ... | Dermagnostix, based in Friedberg and Freiburg, Germany, has successfully closed its EUR 4.6 million ... | bio-m.org/... |
01.12.2021 | Dermagnostix closes seven-digit seed round | The Friedberg-based diagnostics start-up Dermagnostix successfully completed its seed round and rais... | bio-m.org/... |
28.10.2021 | Two diagnostics start-ups among the winners of the 12th &quo... | The winners of the 12th competition phase of the "Start?Zuschuss!" funding program have be... | bio-m.org/... |